A poor NSCLC prognosis and recurrence after surgery have been associated with increased circulating CD15+ LOX-1+ PMN-MDSCs, thus displaying potential as a diagnostic marker for NSCLC. Here, OLR1 is linked to non-small cell lung carcinoma.